This illustration depicts the CPK structure of the anti-cancer agent known as 3-bromopyruvate which is proposed to take advantage of the increased presence of monocarboxylic transporters in highly glycolytic cancers to enter the cell and inhibit the ATP production of both glycolysis and oxidative phosphorylation. This image was created using 3D software for modeling and rendering, and Photoshop for post-production.